Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in Clorox Co (NYSE:CLX) by 14.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 67,063 shares of the company’s stock after buying an additional 8,289 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd.’s holdings in Clorox were worth $11,619,000 as of its most recent SEC filing.
Other hedge funds have also made changes to their positions in the company. Front Row Advisors LLC acquired a new stake in Clorox during the 1st quarter worth $37,000. Northwestern Mutual Wealth Management Co. grew its stake in shares of Clorox by 223.0% during the first quarter. Northwestern Mutual Wealth Management Co. now owns 30,711 shares of the company’s stock worth $5,320,000 after purchasing an additional 21,204 shares during the period. Northwestern Mutual Investment Management Company LLC lifted its stake in Clorox by 34.7% in the first quarter. Northwestern Mutual Investment Management Company LLC now owns 6,570 shares of the company’s stock valued at $1,138,000 after buying an additional 1,694 shares during the period. NewSquare Capital LLC boosted its holdings in Clorox by 2,322.6% during the first quarter. NewSquare Capital LLC now owns 6,420 shares of the company’s stock worth $1,112,000 after buying an additional 6,155 shares during the last quarter. Finally, AGF Investments Inc. bought a new position in Clorox during the first quarter worth about $411,000. 76.45% of the stock is currently owned by hedge funds and other institutional investors.
CLX has been the topic of several recent analyst reports. UBS Group lifted their price objective on shares of Clorox from $155.00 to $168.00 and gave the stock a “sell” rating in a research note on Monday, May 4th. Morgan Stanley boosted their price target on shares of Clorox from $173.00 to $177.00 and gave the company an “underweight” rating in a report on Monday, May 4th. Cfra raised their price objective on Clorox from $170.00 to $190.00 and gave the stock a “hold” rating in a research note on Friday, May 1st. Barclays restated a “sell” rating and issued a $164.00 price target on shares of Clorox in a report on Tuesday, May 5th. Finally, JPMorgan Chase & Co. upgraded Clorox from an “underweight” rating to an “overweight” rating and lifted their price objective for the company from $153.00 to $185.00 in a report on Monday, March 16th. Three investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $173.23.
In other Clorox news, SVP Denise Garner sold 870 shares of the business’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $170.00, for a total transaction of $147,900.00. Following the transaction, the senior vice president now owns 50,489 shares of the company’s stock, valued at approximately $8,583,130. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Benno O. Dorer sold 252,794 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $169.01, for a total value of $42,724,713.94. Following the sale, the chief executive officer now owns 306,908 shares in the company, valued at approximately $51,870,521.08. The disclosure for this sale can be found here. Insiders sold a total of 300,843 shares of company stock worth $52,556,301 over the last quarter. Company insiders own 1.14% of the company’s stock.
Shares of NYSE:CLX traded down $0.81 during mid-day trading on Friday, reaching $198.59. 1,213,707 shares of the stock were exchanged, compared to its average volume of 2,024,068. The stock’s 50 day simple moving average is $193.16 and its 200-day simple moving average is $167.10. Clorox Co has a one year low of $144.12 and a one year high of $214.26. The company has a market cap of $25.11 billion, a P/E ratio of 29.12, a P/E/G ratio of 5.01 and a beta of 0.24. The company has a quick ratio of 0.72, a current ratio of 0.98 and a debt-to-equity ratio of 3.69.
Clorox (NYSE:CLX) last issued its quarterly earnings results on Friday, May 1st. The company reported $1.89 earnings per share for the quarter, topping the consensus estimate of $1.72 by $0.17. Clorox had a net margin of 13.67% and a return on equity of 147.52%. The company had revenue of $1.78 billion during the quarter, compared to analysts’ expectations of $1.69 billion. During the same period last year, the business earned $1.44 EPS. The business’s quarterly revenue was up 15.0% on a year-over-year basis. Analysts anticipate that Clorox Co will post 6.89 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Wednesday, July 29th will be given a $1.11 dividend. The ex-dividend date is Tuesday, July 28th. This represents a $4.44 dividend on an annualized basis and a yield of 2.24%. This is an increase from Clorox’s previous quarterly dividend of $1.06. Clorox’s dividend payout ratio (DPR) is 67.09%.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Recommended Story: What are economic reports?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Co (NYSE:CLX).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.